{
 "name": "博晟生醫",
 "slug": "tw-6733",
 "aliases": [
  "博晟生醫股份有限公司",
  "BioGend",
  "6733"
 ],
 "ticker": "6733",
 "industry": "生技醫療業",
 "website": "https://www.biogend.com.tw/",
 "summary": "博晟生醫（6733）是上櫃的生技醫療類股公司，2016 年成立，2021 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "博晟生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "BioGend",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2021-01-28",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2016-07-07",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "陳德禮",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "陳德禮",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 1343160260,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "https://www.biogend.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 21390,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 9.5,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 7.97,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "管線：BiG001（OIF/Beta-TCP）",
   "value": "開放性脛骨骨折所致骨缺損｜一／二期可行性試驗已公告期末結果，規劃三期｜台灣、美國",
   "unit": "",
   "as_of": "2025-09-15",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=114&month=all&step=2&seq_no=3&spoke_time=154644&spoke_date=20250915&co_id=6733&TYPEK=otc",
   "note": "發言日期：2025-09-15；主旨：公告本公司接獲骨生長因子台美二期臨床試驗結果；NCT04960722（台灣登錄）；美國地區據公告主旨；三期僅規劃，不寫成已啟動。"
  },
  {
   "claim": "主要產品：SoufCut（舒效切軟組織處理系統）",
   "value": "結合軟組織切碎機與酵素處理技術；已接獲第二類醫療器材許可通知",
   "unit": "",
   "as_of": "2026-03-09",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=115&month=all&step=2&seq_no=1&spoke_time=144746&spoke_date=20260309&co_id=6733&TYPEK=otc",
   "note": "發言日期：2026-03-09；主旨：本公司接獲通知「舒效切軟組織處理系統」(SoufCut)取得第二類醫療器材許可證；公告無許可證字號及實際核發日，故不用「產品許可」claim，不將公告日代作核發日。"
  },
  {
   "claim": "授權合作：SuperPore（經銷）",
   "value": "HOYA Technosurgical Corporation｜台灣｜2024-10-14",
   "unit": "",
   "as_of": "2024-10-14",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=113&month=all&step=2&seq_no=1&spoke_time=162816&spoke_date=20241014&co_id=6733&TYPEK=otc",
   "note": "發言日期：2024-10-14；主旨：本公司與日本HOYA Technosurgical Corporation簽訂產品經銷合約；經銷合作；非新藥license-out交易。"
  },
  {
   "claim": "主要產品：RevoCart（愛膝康）",
   "value": "一次性自體軟骨修補系統；已整合BiCRI相關專利與技術",
   "unit": "",
   "as_of": "2026-07-27",
   "source": "https://www.biogend.com.tw/%E5%8D%9A%E6%99%9F%E5%8F%96%E5%BE%97%E6%84%9B%E8%86%9D%E5%BA%B7%E5%AE%8C%E6%95%B4%E6%99%BA%E8%B2%A1%E6%AC%8A-%E5%BC%B7%E5%8C%96%E5%85%A8%E7%90%83%E6%8E%88%E6%AC%8A%E8%88%87%E5%B8%82%E5%A0%B4%E5%B8%83.html"
  },
  {
   "claim": "授權合作：RevoCart／BiCRI（專利與技術讓與）",
   "value": "工研院、臺大醫院｜全球商業化智財｜2026-07-27",
   "unit": "",
   "as_of": "2026-07-27",
   "source": "https://www.biogend.com.tw/%E5%8D%9A%E6%99%9F%E5%8F%96%E5%BE%97%E6%84%9B%E8%86%9D%E5%BA%B7%E5%AE%8C%E6%95%B4%E6%99%BA%E8%B2%A1%E6%AC%8A-%E5%BC%B7%E5%8C%96%E5%85%A8%E7%90%83%E6%8E%88%E6%AC%8A%E8%88%87%E5%B8%82%E5%A0%B4%E5%B8%83.html",
   "note": "技術與專利權讓與；不等同已簽海外對外授權。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6733.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}